Netherlands· NL-586fb77a18e2

Sabril 500 mg granulaat voor drank, granulaat voor drank

A vigabatrin product containing vigabatrine, registered in Netherlands by Sanofi B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC N03AG04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about vigabatrineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Vigabatrin is registered in 17 of 19 countries.

Countries holding a registration under ATC N03AG04 (vigabatrin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search vigabatrin products by name

Vigabatrin · ATC N03AG04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vigabatrin costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $3.20 in Italy to $12.93 in France — a ×4.0 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Vigabatrin · price per daily dose (2 g)

USD · FX 28 Sept 2026

FR France$12.93
CH Switzerland$3.45
IT Italy$3.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: VIGABATRINE
Manufacturer: Sanofi B.V.
Country: Netherlands (NL)
ATC code: N03AG04
ATC class: Vigabatrin
Defined daily dose: 2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
15722

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

115 interactions on record for vigabatrin.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check vigabatrin against other medicines How interaction checks work

Vigabatrin · interactions on record

115 records

31 severe
59 moderate

Most severe, free to view

OxyquinolineA01AB07severe
PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe

25 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vigabatrin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vigabatrin products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Austria · Sabril
Belgium · Sabril
Czechia · Sabril
Germany · Sabril, Sabril Beutel
Denmark · Sabrilex
Spain · Sabrilex, Vigzip
Finland · Sabrilex
France · Sabril, Vigzip
United Kingdom (Northern Ireland) · Sabril, Vigabatrin Zydus Pharmaceuticals Uk
Greece · Sabril
Hungary · Sabril
Ireland · Sabril
Iceland · Kigabeq, Sabrilex
Italy · Sabril, Vigzip
Liechtenstein · Kigabeq
Luxembourg · Sabril
Norway · Kigabeq, Sabrilex
Poland · Sabril
Portugal · Sabril
Sweden · Sabrilex
Slovenia · Sabril
Slovakia · Sabril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d0931e8a-ffec-4da5-97f7-82db4efdafcf
GET /v1/drugs/d0931e8a-ffec-4da5-97f7-82db4efdafcf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat voor drank",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15722_smpc.pdf",
  "strength": null,
  "atc_label": "Vigabatrin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15722",
  "excipients": [
    "POVIDON K 30 (E 1201)"
  ],
  "substances": [
    "VIGABATRINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15722.pdf",
  "authorised_at": "1992/11/10",
  "procedure_number": "FI/H/0139/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "15722",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about vigabatrin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console